Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Sibylla Biotech is a preclinical stage company focused on developing small molecule degraders using a novel mechanism of action to create new therapeutics for unmet medical needs. Their platform…

Sibylla Biotech is a preclinical stage company focused on developing small molecule degraders using a novel mechanism of action to create new therapeutics for unmet medical needs. Their platform…
Stage: Preclinical
Technology: Small-molecule folding interfering degraders (FIDs/PPI-FIT)
Founded: 2017
Headquarters: Bresso (Milan area) / Trento region, Italy
Recent financing: Series A (announced 2022-10-04)
Targeted protein degradation for therapeutic applications
2017
Biotechnology
Round reported with a syndicate of investors (reported total of 8 investors).
“Backed by a syndicate including V-Bio Ventures, Indaco Venture Partners, Seroba Life Sciences and others”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,100+
New This Week